MC-Val-Cit-PAB-MMAF

MC-Val-Cit-PAB-MMAF

MC-Val-Cit-PAB-MMAF is a precursor of antibody drug conjugates (ADCs) with an enzymatically cleavable VAl-Cit site. The maleimide group is reactive with thiol bearing molecules. MMAF is a synthetic antineoplastic agent which may be employed as a cytotoxic payload. The Val-Cit will specifically be cleaved by Cathepsin B.

Molecular structure of the compound BP-27843
    • Unit
    • Price
    • Qty
    • 5 MG
    • $210.00
    • 10 MG
    • $380.00
    • 25 MG
    • $650.00
    • 50 MG
    • $980.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Chao Wang, Jeffrey SOLZAK, Milan Radovich. Compositions and methods for targeting extracellular dna. (WO2024259300A2)
    https://patents.google.com/patent/WO2024259300A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=11
  2. Pistono, P. E., Xu, J., Huang, P., Fetzer, J. L., & Francis, M. B. (2024). Exploring the Effects of Intersubunit Interface Mutations on Virus-Like Particle Structure and Stability. Biochemistry, 63(15), 1913-1924.
    https://doi.org/10.1021/acs.biochem.4c00225